<?xml version="1.0" encoding="UTF-8"?>
<p id="p0129" num="0129" sourceFile="EPÂ 2055697A1.xml">In another embodiment, the present invention provides that after a pharmaceutical composition including a compound of the invention has been formulated in an acceptable carrier, it is placed in an appropriate container and labeled for treatment of an indicated condition. In another embodiment, the present invention provides that for administration of the compounds of this invention, such labeling
  <!-- EPO <DP n="41"> --> would include, e.g., instructions concerning the amount, frequency and method of administration. In another embodiment, the present invention provides that for a kit for the treatment of cancer or kidney failure in a human which includes the compounds of this invention and instructional material teaching the indications, dosage and schedule of administration of the compounds of this invention.
</p>
